Prescribers’ Clinical Support System for Opioid Therapies (PCSS-O) is a three year grant funded by Substance Abuse and Mental Health Services Administration (SAMHSA),Center for Substance Abuse Treatment (CSAT). It is a collaborative project led by American Academy of Addiction Psychiatry (AAAP) with: American Dental Association (ADA), American Medical Association (AMA), American Osteopathic Academy of Addiction Medicine (AOAAM), American Psychiatric Association (APA), American Society for Pain Management Nursing (ASPMN), and International Nurses Society on Addictions (IntNSA). These organizations are providing training and education on the safe and effective prescribing of opioid medications in the treatment of pain and/or opioid addiction.
A webinar offered by American Dental Association (ADA).
About the Webinar: Most patients with nontraumatic dental conditions (NTDCs) present to emergency departments with toothache/pain and receive mainly prescriptions for medications. Although short-term analgesics are critical for managing acute pain, long-term use of analgesics could mask symptoms of underlying injury or disease and create a potential for pain tolerance, substance abuse and exacerbate drug-seeking behavior among addicts of analgesics. The primary aim of this study was to examine emergency department providers’ prescribing practices of opioids, non-opioids, combinations (opioids and non-opioids) and no analgesics for NTDC visits in the United States. A reduction in unnecessary prescription of addictive pain medication is crucial to preventing associated side effects and have potential public policy and program implications.
Date: April 10, 2013
Speaker: Christopher Okunseri, BDS., MSc., MLS., DDPHRCSE., FFDRCSi., Diplomate, American Board of Dental Public Health Director and Association Professor, Marquette University School of Dentistry
Time: 3:00 pm – 4:00 pm ET
To Register: Email Alison Siwek, email@example.com
Funding for this initiative was made possible (in part) by Prescribers’ Clinical Support System for Opioid Therapies (1H79TI023439) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reﬂect the ofﬁcial policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.